Sweden
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
41.01%
|
Dec. 31, 2023 | USD 18.98 | -4.07% |
|
Sweden |
|
2 |
34.27%
|
Dec. 31, 2023 | USD 2.25 | -17.68% |
|
Sweden |
|
3 |
21.05%
|
Dec. 31, 2023 | USD 29.22 | -3.00% |
|
Sweden |
|
4 |
12.44%
|
Dec. 31, 2023 | USD 3.55 | -2.70% |
|
Sweden |
|
5 |
1.80%
|
Dec. 31, 2023 | USD 31.05 | 0.32% |
|
Sweden |
|
6 |
-94.42%
|
Dec. 31, 2023 | USD 0.13 | 0.88% |
|
Sweden |
|
7 |
-126.25%
|
Dec. 31, 2023 | NA | NA |
|
Sweden |
|
8 |
-152.24%
|
Dec. 31, 2023 | USD 0.31 | 1.24% |
|
Sweden |
|
9 |
-353.32%
|
Dec. 31, 2023 | USD 0.71 | 8.98% |
|
Sweden |
|
10 |
-404.81%
|
Aug. 31, 2024 | USD 0.26 | 0.92% |
|
Sweden |
|
11 |
-436.99%
|
Dec. 31, 2023 | USD 0.38 | -3.14% |
|
Sweden |
|
12 |
-517.68%
|
Dec. 31, 2023 | USD 2.43 | -5.44% |
|
Sweden |
|
13 |
-646.72%
|
Dec. 31, 2023 | USD 0.39 | -4.99% |
|
Sweden |
|
14 |
-1,167.55%
|
Dec. 31, 2023 | USD 0.09 | 11.18% |
|
Sweden |
|
15 |
-3,183.60%
|
Dec. 31, 2023 | USD 1.30 | -5.64% |
|
Sweden |
|
16 |
-6,119.26%
|
Dec. 31, 2023 | USD 0.25 | -3.82% |
|
Sweden |
|
17 |
-6,284.25%
|
Dec. 31, 2023 | USD 0.09 | -2.98% |
|
Sweden |
|
18 |
-70,290.57%
|
Dec. 31, 2023 | USD 1.25 | -0.41% |
|
Sweden |
|
19 |
-112,743.85%
|
Aug. 31, 2024 | USD 1.49 | -4.08% |
|
Sweden |
|
20 |
-174,827.27%
|
Dec. 31, 2023 | USD 3.54 | -3.30% |
|
Sweden |
The Vaccines company in Sweden with the highest Operating Income Margin is BioArctic AB (publ) (Stockholm Stock Exchange: BIOA-B.ST) at 41.01%.
The Vaccines company in Sweden with the lowest Operating Income Margin is Infant Bacterial Therapeutics AB (publ) (Stockholm Stock Exchange: IBT-B.ST) at -174,827.27%.
The top 10 Vaccines companies in Sweden by Operating Income Margin are BioArctic AB (publ), Genovis AB (publ.), Swedish Orphan Biovitrum AB (publ), Vimian Group AB (publ), Probi AB (publ), Enzymatica AB (publ), Bio-Works Technologies AB (publ), Elicera Therapeutics AB (publ), Mendus AB (publ) and NextCell Pharma AB.
The bottom 10 Vaccines companies in Sweden by Operating Income Margin are Infant Bacterial Therapeutics AB (publ), Diamyd Medical AB (publ), Lipum AB (publ), Kancera AB (publ), Alzinova AB (publ), IRLAB Therapeutics AB (publ), Intervacc AB (publ), Iconovo AB (publ), BioInvent International AB (publ) and Pila Pharma AB (publ).